Literature DB >> 17033832

Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients.

Juliana Guarize1, Simone Appenzeller, Lílian Tereza Lavras Costallat.   

Abstract

To determine if skin damage is related to disease duration in Brazilian patients with SLE followed in a tertiary reference center through the application of standardized damage index (SLICC/ACR-DI). Sixty SLE patients were enrolled in this study. Relevant data were obtained through patients' interview, physical and laboratory examinations and review of the hospital records. The frequency and the different types of organ damage were determined using de SLICC/ACR-DI. Statistics were performed through chi-square and Student's t tests. Multivariate regression was used to correlate damage with disease duration. Forty-one (68.3%) patients presented any type of cumulative organ damage. The skin (35%), renal (23.3%) and neuropsychiatric (18.3%) systems were the most frequently involved, followed by peripheric vascular, ocular and cardiovascular systems. Non-Caucasoid patients and patients with longer disease duration had a slight tendency for greater organ damage (P = 0.05). Skin damage occurred independently of disease duration, whereas cardiovascular (P = 0.051), peripheral vascular (P = 0.057) and pulmonary damage (P = 0.06) had a tendency to occur more frequently in patients with longer disease duration. In this study, 68.3% of permanent damage was observed. An elevated frequency of skin damage was observed in this population which occurred independently of disease duration. Non-Caucasian patients had a tendency to present higher scores, but more studies are necessary to determine if ethnic or economic factors are involved.

Entities:  

Mesh:

Year:  2007        PMID: 17033832     DOI: 10.1007/s00296-006-0240-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  Hopkins Lupus Cohort. 1999 update.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  2000-05       Impact factor: 2.670

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.

Authors:  T Stoll; G Stucki; J Malik; S Pyke; D A Isenberg
Journal:  J Rheumatol       Date:  1997-02       Impact factor: 4.666

4.  Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region.

Authors:  Maria José Pereira Vilar; Elaine Lira Medeiros Bezerra; Emilia Inoue Sato
Journal:  Clin Rheumatol       Date:  2004-12-14       Impact factor: 2.980

5.  Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.

Authors:  K E Moss; Y Ioannou; S M Sultan; I Haq; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

6.  The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus.

Authors:  E W Karlson; L H Daltroy; R A Lew; E A Wright; A J Partridge; A H Fossel; W N Roberts; S H Stern; K V Straaton; M C Wacholtz; A F Kavanaugh; J M Grosflam; M H Liang
Journal:  Arthritis Rheum       Date:  1997-01

7.  Mortality and causes of death in systemic lupus erythematosus.

Authors:  J Trager; M M Ward
Journal:  Curr Opin Rheumatol       Date:  2001-09       Impact factor: 5.006

8.  Damage accrual in southern Chinese patients with systemic lupus erythematosus.

Authors:  Chi Chiu Mok; Carmen Tze Kwan Ho; Raymond Woon Sing Wong; Chak Sing Lau
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

View more
  6 in total

Review 1.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

2.  Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Luis A González; Jie Zhang; Luis M Vilá; John D Reveille; Gerald McGwin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 3.  Global trends, potential mechanisms and early detection of organ damage in SLE.

Authors:  Anselm Mak; David A Isenberg; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2012-12-11       Impact factor: 20.543

4.  Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus.

Authors:  Zahra Sayed Bonakdar; Negin Mohtasham; Mansoor Karimifar
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

5.  Correlations of Expression Levels of a Panel of Genes (IRF5, STAT4, TNFSF4, MECP2, and TLR7) and Cytokine Levels (IL-2, IL-6, IL-10, IL-12, IFN-γ, and TNF-α) with Systemic Lupus Erythematosus Outcomes in Jordanian Patients.

Authors:  Amal H Uzrail; Areej M Assaf; Shtaywy S Abdalla
Journal:  Biomed Res Int       Date:  2019-11-29       Impact factor: 3.411

6.  Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies.

Authors:  Manuel Francisco Ugarte-Gil; Anselm Mak; Joanna Leong; Bhushan Dharmadhikari; Nien Yee Kow; Cristina Reátegui-Sokolova; Claudia Elera-Fitzcarrald; Cinthia Aranow; Laurent Arnaud; Anca D Askanase; Sang-Cheol Bae; Sasha Bernatsky; Ian N Bruce; Jill Buyon; Nathalie Costedoat-Chalumeau; Mary Ann Dooley; Paul R Fortin; Ellen M Ginzler; Dafna D Gladman; John Hanly; Murat Inanc; David Isenberg; Soren Jacobsen; Judith A James; Andreas Jönsen; Kenneth Kalunian; Diane L Kamen; Sung Sam Lim; Eric Morand; Marta Mosca; Christine Peschken; Bernardo A Pons-Estel; Anisur Rahman; Rosalind Ramsey-Goldman; John Reynolds; Juanita Romero-Diaz; Guillermo Ruiz-Irastorza; Jorge Sánchez-Guerrero; Elisabet Svenungsson; Murray Urowitz; Evelyne Vinet; Ronald F van Vollenhoven; Alexandre Voskuyl; Daniel J Wallace; Michelle A Petri; Susan Manzi; Ann Elaine Clarke; Mike Cheung; Vernon Farewell; Graciela S Alarcon
Journal:  Lupus Sci Med       Date:  2021-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.